Stockreport

Trevi Therapeutics Announces Positive Topline Results from Human Abuse Potential Study of Oral Nalbuphine [Yahoo! Finance]

Trevi Therapeutics, Inc.  (TRVI) 
PDF Company to host a conference call and webcast today at 5:00 p .m. ET NEW HAVEN, Conn. Dec. 3, 2024 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical [Read more]